$25.4B
$493 Million
0.04% of portfolio
6,928
Q3 2025
New
$38.8B
$423 Million
0.04% of portfolio
2,613
Q3 2025
New
$39.2B
$513 Million
0.04% of portfolio
3,062
Q3 2025
New
$13.9B
$514 Million
0.04% of portfolio
3,658
Q3 2025
Reduced 6.3%
$27.1B
$522 Million
0.04% of portfolio
955
Q3 2025
New
$5.75B
$497 Million
0.04% of portfolio
14,398
Q3 2025
New
$19.2B
$302 Million
0.03% of portfolio
3,694
Q3 2025
New
-
$336 Million
0.03% of portfolio
-
Q3 2025
Reduced 3.76%
$1.4B
$365 Million
0.03% of portfolio
6,250
Q3 2025
New
$18.6B
$358 Million
0.03% of portfolio
7,298
Q3 2025
New
$2.52B
$315 Million
0.03% of portfolio
6,632
Q3 2025
Reduced 35.23%
$25.8B
$303 Million
0.03% of portfolio
1,224
Q3 2025
New
$16.4B
$314 Million
0.03% of portfolio
12,660
Q3 2025
New
$12.6B
$332 Million
0.03% of portfolio
40,619
Q3 2025
New
$12.2B
$326 Million
0.03% of portfolio
1,667
Q3 2025
New
$25.7B
$401 Million
0.03% of portfolio
2,406
Q3 2025
New
$390M
$377 Million
0.03% of portfolio
173,872
Q3 2025
New
$26.1B
$345 Million
0.03% of portfolio
2,181
Q3 2025
New
$10.4B
$341 Million
0.03% of portfolio
3,209
Q3 2025
New
$16.4B
$327 Million
0.03% of portfolio
17,508
Q3 2025
New
$24.8B
$370 Million
0.03% of portfolio
1,917
Q3 2025
New
$30.4B
$413 Million
0.03% of portfolio
15,849
Q3 2025
New
$50B
$328 Million
0.03% of portfolio
6,103
Q3 2025
New
$19.9B
$408 Million
0.03% of portfolio
4,626
Q3 2025
New
$26.1B
$385 Million
0.03% of portfolio
2,040
Q3 2025
New
$31.2B
$383 Million
0.03% of portfolio
2,346
Q3 2025
New
$32.3B
$389 Million
0.03% of portfolio
1,970
Q3 2025
New
$31.6B
$325 Million
0.03% of portfolio
265
Q3 2025
New
$25.6B
$409 Million
0.03% of portfolio
7,685
Q3 2025
New
$6B
$412 Million
0.03% of portfolio
5,981
Q3 2025
New
$16.9B
$306 Million
0.03% of portfolio
2,277
Q3 2025
New
$22.4B
$384 Million
0.03% of portfolio
6,940
Q3 2025
New
$29.5B
$391 Million
0.03% of portfolio
602
Q3 2025
New
$22.5B
$361 Million
0.03% of portfolio
5,584
Q3 2025
New
$14.5B
$382 Million
0.03% of portfolio
1,090
Q3 2025
New
$21B
$326 Million
0.03% of portfolio
13,766
Q3 2025
New
$40.2B
$361 Million
0.03% of portfolio
1,687
Q3 2025
New
$27B
$337 Million
0.03% of portfolio
1,529
Q3 2025
New
$18.3B
$366 Million
0.03% of portfolio
1,393
Q3 2025
New
$20.5B
$320 Million
0.03% of portfolio
3,856
Q3 2025
New
$24.8B
$393 Million
0.03% of portfolio
15,989
Q3 2025
New
$26.3B
$414 Million
0.03% of portfolio
2,213
Q3 2025
New
$20.8B
$355 Million
0.03% of portfolio
2,638
Q3 2025
New
$22.8B
$403 Million
0.03% of portfolio
4,293
Q3 2025
New
$34.9B
$372 Million
0.03% of portfolio
1,563
Q3 2025
New
-
$323 Million
0.03% of portfolio
-
Q3 2025
New
Ascentage Pharma Group Intl
-
$405 Million
0.03% of portfolio
-
Q3 2025
Reduced 32.98%
$1.45B
$412 Million
0.03% of portfolio
30,293
Q3 2025
Reduced 49.23%
$23.3B
$314 Million
0.03% of portfolio
11,921
Q3 2025
New
$14.7B
$398 Million
0.03% of portfolio
4,877
Q3 2025
New